Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-9,397
Closed -$543K 91
2015
Q1
$543K Sell
9,397
-7,308
-44% -$419K 0.23% 64
2014
Q4
$893K Sell
16,705
-21,678
-56% -$1.21M 0.39% 55
2014
Q3
$2.21M Buy
38,383
+11,651
+44% +$714K 1% 37
2014
Q2
$1.79M Buy
26,732
+1,236
+5% +$83.7K 1.19% 37
2014
Q1
$1.7M Buy
25,496
+1,620
+7% +$110K 1.15% 38
2013
Q4
$1.59M Buy
23,876
+14,364
+151% +$931K 1.1% 39
2013
Q3
$595K Buy
9,512
+6,212
+188% +$400K 0.46% 47
2013
Q2
$206K Buy
+3,300
New +$209K 0.17% 67

Other funds holding GSK

Stephen W. Kidder's GSK Position: Q2 2015 in Review

Stephen W. Kidder sold out of GSK (GSK) in Q2 2015, closing a stake of 9,397 shares — an estimated $543K sold.

Stephen W. Kidder first reported a position in GSK in Q2 2013 and held it in 8 quarters. The position peaked at $2.21M in Q3 2014. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • Stephen W. Kidder reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
  • Stephen W. Kidder sold 9,397 GSK shares in Q2 2015, an estimated $543K.
  • Stephen W. Kidder first reported a position in GSK in Q2 2013 and held it in 8 quarters.
  • Stephen W. Kidder's GSK position peaked at $2.21M in Q3 2014.
  • 719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Stephen W. Kidder's 13F filing for Q2 2015, filed 10 Aug 2015.